Hrt Financial LP Mirati Therapeutics, Inc. Transaction History

Hrt Financial LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$41.99 - $62.38 $2.08 Million - $3.09 Million	49,526 New	49,526 $2.91 Million
Q2 2023 Aug 11, 2023	SELL	$36.13 - $49.49 $290,123 - $397,404	-8,030 Reduced 9.88%	73,276 $2.65 Million
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $2.97 Million - $4.41 Million	81,306 New	81,306 $3.02 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $227,885 - $332,061	3,830 New	3,830 $267,000
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $2.38 Million - $4.74 Million	-31,382 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $4.14 Million - $5.97 Million	31,382 New	31,382 $4.6 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $15.6 Million - $21 Million	-118,131 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $17 Million - $21.2 Million	118,131 New	118,131 $19.1 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $4.7 Million - $6.55 Million	-29,567 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $4.79 Million - $7.1 Million	29,567 New	29,567 $6.49 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $828,691 - $1.39 Million	-11,508 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $803,028 - $1.34 Million	11,508 New	11,508 $884,000
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $1.93 Million - $3.52 Million	-27,338 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $2.13 Million - $3 Million	27,338 New	27,338 $2.13 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.